Efficacy and safety of needle-free jet injector-assisted intralesional treatments in dermatology—a systematic review

Vazula Zulfra Bekkers*, Liora Bik, Johanna Catharina van Huijstee, Albert Wolkerstorfer, Errol Prospero Prens, Martijn Bastiaan Adriaan van Doorn

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

1 Citation (Scopus)
52 Downloads (Pure)

Abstract

Needle-free jet injectors are used for the intralesional treatment of various dermatological indications. However, a systematic review that evaluates the efficacy and safety of these treatments has not been published. The objectives of this study are to evaluate the efficacy and safety of needle-free jet injections for dermatological indications and to provide evidence-based treatment recommendations. An electronic literature search was conducted in April 2022. Two reviewers independently selected studies based on predefined criteria and performed a methodological quality assessment using the Cochrane Collaborations risk-of-bias 2.0 assessment tool and Newcastle–Ottawa Scale. Thirty-seven articles were included, involving 1911 participants. Dermatological indications included scars, alopecia areata, hyperhidrosis, nail diseases, non-melanoma skin cancer, common warts, local anesthesia, and aesthetic indications. Keloids and other types of scars (hypertrophic, atrophic, and burn scars) were investigated most frequently (n = 7). The included studies reported favorable efficacy and safety outcomes for intralesional jet injector-assisted treatment with triamcinolone acetonide/hexacetonide, 5-fluorouracil, bleomycin, or hyaluronic acid. Two high-quality studies showed good efficacy and tolerability of intralesional jet injections with a combination of 5-fluorouracil and triamcinolone acetonide in hypertrophic scars and with saline in boxcar and rolling acne scars. No serious adverse reactions and good tolerability were reported in the included studies. Overall, the methodological quality of the included studies was low. Limited evidence suggests that needle-free jet injector-assisted intralesional treatment is efficacious and safe for hypertrophic and atrophic acne scars. More well-powered RCTs investigating the efficacy and safety of jet injector treatment in dermatology are warranted to make further evidence-based recommendations. Graphical Abstract: [Figure not available: see fulltext.].

Original languageEnglish
Pages (from-to)1584-1599
Number of pages16
JournalDrug Delivery and Translational Research
Volume13
Issue number6
Early online date8 Mar 2023
DOIs
Publication statusPublished - Jun 2023

Bibliographical note

Funding Information:
We thank Wichor M. Bramer, biomedical information specialist at Erasmus MC Rotterdam, for his contribution to the electronic database search.

Publisher Copyright:
© 2023, The Author(s).

Fingerprint

Dive into the research topics of 'Efficacy and safety of needle-free jet injector-assisted intralesional treatments in dermatology—a systematic review'. Together they form a unique fingerprint.

Cite this